pharmaceutical companies news from FierceHealthcare
NewsConflicts of interest remain as docs receive $760M from drug makers
Physicians continue to struggle with conflicts of interest related to accepting payments for promotional work for pharmaceutical companies as a new report shows drug makers paid more than $760 Read more...
Colorado teaching hospitals overhaul conflict of interest rules
The University of Colorado Denver and its teaching hospitals will revamp conflict of interest policies after a ProPublica story published last month revealed professors and physicians were raking in Read more...
Big drug companies wield too much influence over doctors
Most consumers don't think doctors should have such a tight relationship with big pharma, according to the second annual prescription drug survey conducted by Consumer Reports National Research Read more...
Study: Attitudes over doctor-industry ties not as evolved as we think
Despite the negative attention recently cast on physician-industry ties, a new study by researchers at Mount Sinai School of Medicine reveals that most individual physicians are still welcoming of Read more...
SPOTLIGHT: Relationships between docs, drug companies also a problem in India
Looks like the issue of conflicts of interest between doctors and pharmaceutical companies isn't just limited to the U.S. According to the Wall Street Journal's Health Blog, physicians in that Read more...
Price hikes could raise $10 billion in additional income for pharmas
Pharmaceutical companies have been asked to help fund health reform by cutting drug costs $8 billion per year over the next 10 years. But while this sounds good, drugmakers may be taking steps to Read more...
Pharma price reforms are badly needed
Well, folks, it looks like we're on the verge of getting a parcel of health insurance reforms pushed through Congress. Health insurance reform isn't precisely health system reform, but it does Read more...
Reform bill would require pharma disclosures of CME funding
While it's gotten relatively little attention from pundits, provisions within reform bills passing through Congress would demand that pharmaceutical companies disclose how they're spending on Read more...
Pharmas settle $124M Medicaid fraud suit; Legislators fight for 'critical access' funding for rural hospitals;
> Four pharmaceutical companies--Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceuticals-- have agreed to pay $124 million to resolve claims that Read more...
CME accreditation body plans exposure of courses violating drugmaker influence rules
To remain certified, doctors must take continuing medical education courses each year. With about half of the $1 billion per year cost of these courses being picked up by pharmaceutical companies, Read more...
| Press ReleasesIMS Acquires PharmARC in India, Strengthening Global Services CapabilitiesDANBURY, Conn.--(BUSINESS WIRE)-- IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds Read more >> DecisionView Enhances Market-Leading Clinical Enrollment Optimization Solution With Improved Cost ModelingDecisionView StudyOptimizer 4.4 Enables Clinical Trial Organizations To Easily Create and Compare Enrollment Scenarios With Different Timelines and CostsSAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- Read more >> Internal Documents Reveal USDA Dietary Guidelines Panel Dominated by ADAWASHINGTON--(BUSINESS WIRE)-- Under pressure from the Healthy Nation Coalition, the USDA revealed identities of the 2010 Dietary Guidelines “Independent Scientific Review Panel,” credited with Read more >> Arlington Medical Resources to Release Analysis of the Complicated Skin and Skin Structure Infections Market in EuropeReport Analyzes Dynamics of Product Usage, Physicians’ Treatment Patterns and Patient Population EXTON, Pa.--(BUSINESS WIRE)-- Arlington Medical Resources (AMR), a provider of premier market Read more >> Trialing New Medical Products Gets Faster and More SecureLONGMONT, Colo., Dec. 13, 2011 /PRNewswire/ -- Data security and accuracy is vital to all industries, particularly in the health field. The process by which a pharmaceutical company compiles and Read more >> |
